Literature DB >> 23010737

Elevated CEA levels and low distance of the tumor from the anal verge are predictors of incomplete response to chemoradiation in patients with rectal cancer.

Angelo Restivo1, Luigi Zorcolo, Ivana Maria Francesca Cocco, Romina Manunza, Carla Margiani, Luigi Marongiu, Giuseppe Casula.   

Abstract

BACKGROUND: The objective of this study was to evaluate pretreatment clinical parameters as predictive factors for complete pathological response after long-term chemoradiotherapy (RCT) for rectal cancer. Tumor downstaging after RCT for rectal cancer can be obtained in half of cases, whereas a complete pathological response (CPR) is reported to range between 15 and 30%. It is not possible to foresee before therapies who will respond.
METHODS: Patients with stage II-III rectal cancer that had undergone RCT and rectal resection between January 1995 and October 2010 were considered. Patients were divided in those who achieved a CPR, "CR" group, and those who did not achieve a CPR, "NCR" group. Univariate and multivariate analyses between groups were performed considering the clinical parameters: gender, age, ASA score, preoperative hematic CEA, tumor grading; distance of the tumor from the anal verge, maximum tumor diameter, TNM stage, and neoadjuvant treatment details.
RESULTS: Among 260 patients, 43 (16.5%) achieved a CPR. The two groups resulted homogeneous for age, sex, pretreatment status, and tumor stage. A CEA <5 ng/dl and distance from anal verge >5 cm were correlated with CPR at multivariate analysis. Patients with both these conditions presented a significantly higher CPR rate (30.6%) as well as improved 5-year survival. CPR was also correlated with improved survival.
CONCLUSIONS: Very low tumors with a high serum CEA are very unlikely to reach a CPR. The predictive value of these easily available clinical factors should not be underestimated, and better therapeutic strategies for these tumors are needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010737     DOI: 10.1245/s10434-012-2669-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  33 in total

1.  Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer.

Authors:  Ariella Kleiman; Ahmed Al-Khamis; Ali Farsi; Abbas Kezouh; Te Vuong; Philip H Gordon; Carol-Ann Vasilevsky; Nancy Morin; Julio Faria; Gabriela Ghitulescu; Marylise Boutros
Journal:  J Gastrointest Surg       Date:  2015-04-10       Impact factor: 3.452

2.  Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.

Authors:  Sunil V Patel; Campbell S Roxburgh; Efsevia Vakiani; Jinru Shia; J Joshua Smith; Larissa K Temple; Philip Paty; Julio Garcia-Aguilar; Garrett Nash; Jose Guillem; Abraham Wu; Marsha Reyngold; Martin R Weiser
Journal:  J Surg Oncol       Date:  2016-09-19       Impact factor: 3.454

3.  Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs.

Authors:  Xiaoling Duan; Man Zhao; Shenglei Zhang; Zhibin Xu; Lili Mi; Jianfei Shi; Xiaoying Ma; Yueping Liu; Ning Li; Xiaolei Yin; Xin Han; Guangjie Han; Jinfeng Wang; Jinsheng Xu; Fei Yin
Journal:  Int J Colorectal Dis       Date:  2020-04-20       Impact factor: 2.571

4.  Pathologic response following treatment for locally advanced rectal cancer: Does location matter?

Authors:  William H Ward; Elin R Sigurdson; Andrew C Esposito; Karen J Ruth; Samuel M Manstein; Eric C Sorenson; Brian D Wernick; Jeffrey M Farma
Journal:  J Surg Res       Date:  2018-01-04       Impact factor: 2.192

5.  Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer.

Authors:  Gota Saito; Sotaro Sadahiro; Takashi Ogimi; Hiroshi Miyakita; Kazutake Okada; Akira Tanaka; Toshiyuki Suzuki
Journal:  Oncology       Date:  2017-12-22       Impact factor: 2.935

6.  How to accurately measure the distance from the anal verge to rectal cancer on MRI: a prospective study using anal verge markers.

Authors:  Yeo Eun Han; Beom Jin Park; Deuk Jae Sung; Min Ju Kim; Na Yeon Han; Ki Choon Sim; Sung Bum Cho; Jin Kim; Seon-Hahn Kim; Hyonggin An
Journal:  Abdom Radiol (NY)       Date:  2020-07-20

Review 7.  Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis.

Authors:  Giuseppe Colloca; Antonella Venturino; Pasquale Vitucci
Journal:  Med Oncol       Date:  2017-09-07       Impact factor: 3.064

8.  Watch and Wait?--Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer.

Authors:  Christian P Probst; Adan Z Becerra; Christopher T Aquina; Mohamedtaki A Tejani; Bradley J Hensley; Maynor G González; Katia Noyes; John R T Monson; Fergal J Fleming
Journal:  J Gastrointest Surg       Date:  2015-11-06       Impact factor: 3.452

9.  Association of pretreatment serum carcinoembryonic antigen levels with chemoradiation-induced downstaging and downsizing of rectal cancer.

Authors:  Seung-Gu Yeo
Journal:  Mol Clin Oncol       Date:  2016-01-25

10.  Impact of delaying surgery after chemoradiation in rectal cancer: outcomes from a tertiary cancer centre in India.

Authors:  Praveen Kammar; Aditi Chaturvedi; Masillamany Sivasanker; Ashwin de'Souza; Reena Engineer; Vikas Ostwal; Avanish Saklani
Journal:  J Gastrointest Oncol       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.